6533b823fe1ef96bd127ed6c

RESEARCH PRODUCT

Red Cell Filterability and Erythrocyte Membrane Microviscosity during Ticlopidine Treatment

Anna CataniaGiuseppe FrancavillaSerra AAntonio SarnoR. Lo PrestiGregorio Caimi

subject

MaleTiclopidineArteriosclerosis030204 cardiovascular system & hematologyPharmacologyBiochemistryMicroviscosity03 medical and health sciences0302 clinical medicineErythrocyte DeformabilitymedicineHumansErythrocyte deformabilityTiclopidineRed CellViscositybusiness.industryErythrocyte MembraneBiochemistry (medical)Cell BiologyGeneral MedicineArteriosclerosismedicine.diseaseRed blood cellErythrocyte membranemedicine.anatomical_structureMechanism of actionBiochemistry030220 oncology & carcinogenesisFemalemedicine.symptomRheologybusinessmedicine.drug

description

The effects of 10 days' treatment with 500 mg/day ticlopidine on the filterability of red blood cells in suspension and on the microviscosity of the red blood cell membrane was evaluated in 11 patients with vascular atherosclerosis. The results show ticlopidine to be effective in influencing the rheological measures of red cell filterability and membrane microviscosity: filterability was increased and microviscosity was decreased. Ticlopidine also decreased the extent of fluorescence polarization. These results are discussed regarding possible mechanisms of action of ticlopidine.

https://doi.org/10.1177/030006059001800210